A vulnerability was found in Oracle Health Sciences Empirica Signal 7.3.3 (Medical Device Software). It has been rated as very critical. This issue affects an unknown functionality of the component Web server. The manipulation with an unknown input leads to a input validation vulnerability. Using CWE to declare the problem leads to CWE-20. The product receives input or data, but it does not validate or incorrectly validates that the input has the properties that are required to process the data safely and correctly. Impacted is confidentiality, integrity, and availability.

The weakness was disclosed 07/15/2020 as Oracle Critical Patch Update Advisory - July 2020 as confirmed advisory (Website). It is possible to read the advisory at oracle.com. The identification of this vulnerability is CVE-2020-1938. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. Technical details are unknown but an exploit is available. The pricing for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 04/23/2024).

It is declared as highly functional. We expect the 0-day to have been worth approximately $25k-$100k. The CISA Known Exploited Vulnerabilities Catalog lists this issue since 03/03/2022 with a due date of 03/17/2022:

Apply updates per vendor instructions.

Upgrading eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability.

The entries 150441, 158073, 158074 and 158075 are pretty similar.

Productinfo

Type

• Medical Device Software

Vendor

• Oracle

Name

• Health Sciences Empirica Signal

Version

• 7.3.3

License

• commercial

CPE 2.3info

• 🔍
• 🔍
• 🔍

CPE 2.2info

• 🔍
• 🔍
• 🔍

CVSSv4info

CVSSv3info

CVSSv2info

Exploitinginfo

Threat Intelligenceinfo

Countermeasuresinfo

Timelineinfo

Sourcesinfo

Entryinfo

Discussion